Fibroblast activation in sarcoidosis as assessed by 68Ga-FAPI (fibroblast activation protein inhibitor)-46 PET/CT

O’Brien S, Musameh K, Obeid ME, Butler T, Armstrong M, Cunningham Z, Atzinger A, Kuwert T, Mitchell PD, Donnelly SC (2024)

Publication Type: Journal article

Publication year: 2024

Journal

Qjm-An International Journal of Medicine Oxford University Press (OUP): Policy B - Oxford Open Option D

Book Volume: 117

Pages Range: 603-604

Journal Issue: 8

DOI: 10.1093/qjmed/hcae067

Authors with CRIS profile

Armin Atzinger Department of Nuclear Medicine Torsten Kuwert Lehrstuhl für Klinische Nuklearmedizin

Involved external institutions

Trinity College Dublin IE Ireland (IE)

How to cite

APA:

O’Brien, S., Musameh, K., Obeid, M.E., Butler, T., Armstrong, M., Cunningham, Z.,... Donnelly, S.C. (2024). Fibroblast activation in sarcoidosis as assessed by 68Ga-FAPI (fibroblast activation protein inhibitor)-46 PET/CT. Qjm-An International Journal of Medicine, 117(8), 603-604. https://doi.org/10.1093/qjmed/hcae067

MLA:

O’Brien, S., et al. "Fibroblast activation in sarcoidosis as assessed by 68Ga-FAPI (fibroblast activation protein inhibitor)-46 PET/CT." Qjm-An International Journal of Medicine 117.8 (2024): 603-604.

BibTeX: Download